Mayinglong Pharmaceutical Group Co., Ltd. Class ASSE: 600993

Report for Q3 2025

Oct 30, 2025 · Issued by Mayinglong Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment